Uterine Carcinosarcoma Associated with Tamoxifen Use in a Menopausal Patient: A Case Report
نویسنده
چکیده
منابع مشابه
Synchronous uterine carcinosarcoma and contralateral breast cancer after tamoxifen therapy: a case report.
Uterine carcinosarcoma (malignant mixed Müllerian tumor, MMMT) is a rare aggressive malignant tumor, which demonstrates both malignant epithelial (carcinoma) and mesenchymal (sarcoma) components. Synchronous uterine carcinosarcoma and contralateral breast cancer in patient received tamoxifen treatment had not been reported. We present a case of uterine carcinosarcoma co-occurrenced with contral...
متن کاملMalignant Mixed Mullerian Tumor of the Uterus Associated with Tamoxifen Therapy in a Patient with a History of Breast Cancer
Tamoxifen is the drug of choice in the treatment of breast cancer. Recent reports show an increased incidence of endometrial carcinoma in patients taking tamoxifen. In this article, we report a case of malignant mixed mullerian tumor after tamoxifen use.
متن کاملA Case Report of a Severely Aggressive Uterine Sarcoma at an Unusual Age
Uterine sarcomas are very unique tumors with mesodermial origin and accounting for 2-6% of uterine cancers. In general, uterine sarcomas are the most malignant tumors of the uterus. Their usual histologic types are endometrial estromal sarcoma, lieomyosarcoma and malignant mixed mullerian tumor or carcinosarcoma In this case report, a 19 year old woman with chief complaint of abnormal ute...
متن کاملCarcinosarcoma of the Maxillary Sinus: A Case Report
Carcinosarcoma is a highly malignant tumour exhibiting histological components of both carcinomatous and sarcomatoid elements. Carcinosarcoma is extremely rare in the sinonasal cavity. Due to the rarity and clinical diversity, these neoplasms are often misdiagnosed and pose a challenge in their management. Here we report a 44-year-old man with epistaxis and progressive symptoms of nasal obstru...
متن کاملEndometrial mullerian adenosarcoma after toremifene treatment in breast cancer patients: a case report.
Toremifene is an anti-estrogen which has been shown to be effective in the treatment of breast cancer, and is thought to be a less uterotrophic agent than tamoxifen. The risk assessment concerning endometrial cancer has been inconclusive because of its rare use up to the mid-1990s. We report a case of an adenosarcoma, which is a very rare type of uterine malignancy, after toremifene treatment f...
متن کامل